Home / Health / Private Cancer Care Risk: Coroner Warns of Inferior Treatment
Private Cancer Care Risk: Coroner Warns of Inferior Treatment
15 Apr
Summary
- Coroner warns private skin cancer patients may receive substandard care.
- A man's death highlighted potential gaps in private healthcare referrals.
- National guidelines are inconsistently applied in private settings.
A coroner has raised serious concerns about the quality of care for private skin cancer patients, suggesting it could be inferior to that provided by the NHS. The warning follows the death of 81-year-old Gary Starbuck, who had been treated for skin cancer that later spread. An inquest into his death highlighted a potential gap in specialist referrals for high-risk private patients.
Coroner Darren Stewart noted in a report that private patients risk receiving substandard care, even within the same hospital facilities as NHS patients. This disparity stems from inconsistent application of national guidelines, such as those from the National Institute for Health and Care (Nice). While mandatory for the NHS, their use in private healthcare settings is less clear, potentially impacting patient outcomes.
The report has been sent to regulatory bodies like the Care Quality Commission and the Royal College of Surgeons, urging them to address these findings to prevent future deaths. Both organizations have acknowledged the coroner's concerns and emphasized the need for learning and ensuring high-quality care for all patients, regardless of their treatment setting.
